Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
Authors:
Open Access
- 1 December 2016
- journal article
- research article
- Published by Taylor & Francis in Research and Reports in Urology
- Vol. ume 8, 225-231
Abstract
Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy Yutaka Yamamoto,1 Keisuke Kiba,1 Motokiyo Yoshikawa,1 Akihide Hirayama,1 Seiji Kunikata,1 Hirotsugu Uemura2 1Department of Urology, Nara Hospital, Kindai University Faculty of Medicine, Ikoma, 2Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Japan Objective: The aim of this study was to evaluate the biochemical recurrence (BCR) in patients with high-risk prostate cancer (PCa) treated with radical prostatectomy (RP) or radiotherapy (RT) plus androgen deprivation therapy (ADT).Methods: Subjects were patients with National Comprehensive Cancer Network-defined high-risk PCa treated with either RP or RT plus ADT. We calculated BCR-free survival in patients with those treatments and evaluated risk factor against BCR.Results: A total of 114 patients, 71 RP and 43 RT plus ADT, were evaluated. A total of 59 and 20.9% of patients experienced BCR in the RP and RT treatment groups, respectively. The 5-year BCR-free survival probabilities improved significantly for patients who received RT compared to those who received RP (81.3 vs 37.3%, P<0.001). According to the number of risk factors, 59.2% of patients in the RP and 51.2% of patients in the RT treatment groups were classified with one risk factor (P<0.014). The 5-year BCR-free survival probabilities for patients treated with RP were 46.6 and 21.7% for one and multiple risk factors, respectively (P=0.008). On univariate analysis, only the number of risk factors had a significant impact on the risk of BCR. Meanwhile, there were no significant differences in the 5-year BCR-free survival probabilities between one and multiple risk factors in patients treated with RT.Conclusion: Among patients treated with RP, a marked heterogeneity existed in the oncological outcomes. Based on these findings, the number of risk factors should be emphasized to decide the optimal treatments for patients with high-risk PCa. Keywords: high-risk prostate cancer, radical prostatectomy, radiotherapy plus androgen deprivation therapy, biochemical recurrence, number of risk factorsKeywords
This publication has 29 references indexed in Scilit:
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013European Urology, 2014
- Long‐term survival after radical prostatectomy versus external‐beam radiotherapy for patients with high‐risk prostate cancerCancer, 2011
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised DiseaseEuropean Urology, 2011
- Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancerCancer, 2010
- Metastasis After Radical Prostatectomy or External Beam Radiotherapy for Patients With Clinically Localized Prostate Cancer: A Comparison of Clinical Cohorts Adjusted for Case MixJournal of Clinical Oncology, 2010
- Time Trends and Local Variation in Primary Treatment of Localized Prostate CancerJournal of Clinical Oncology, 2010
- Retrospective Comparison of External Beam Radiotherapy and Radical Prostatectomy in High-Risk, Clinically Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Predicting Prostate Cancer Mortality Among Men With Intermediate to High-Risk Disease and Multiple Unfavorable Risk FactorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- A Randomized Trial Comparing Radical Prostatectomy Plus Endocrine Therapy versus External Beam Radiotherapy Plus Endocrine Therapy for Locally Advanced Prostate Cancer: Results at Median Follow-up of 102 MonthsJapanese Journal of Clinical Oncology, 2006
- Case-Matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006